Ferdinand J. Venditti
Lahey Hospital & Medical Center
43 Papers
470 Citations
Ferdinand J. Venditti is an academic researcher from Lahey Hospital & Medical Center. The author has contributed to research in topics: Medicine & Implantable cardioverter-defibrillator. The author has an hindex of 17, co-authored 37 publications. Previous affiliations of Ferdinand J. Venditti include Tufts Medical Center & Harvard University.
Chat about Author
Papers
Electrical proarrhythmia with procainamide: a new ICD-drug interaction.
TL;DR: The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported electrophysiologic effect of, or idiosyncratic response to, procainamide.
2
Use of event markers during exercise testing to optimize morphology criterion programming of implantable defibrillator.
TL;DR: Clinical, electrocardiographic, and implantation data are unreliable in predicting satisfaction of the morphology criterion during high heart rates in native rhythm and formal exercise testing in the electrophysiological mode enables a rational decision to be made about the appropriateness of the use of probability density function in each patient.
2
Revised Implantation Procedure for Programmable Automatic Implantable Cardioverter Defibrillator: Don't Discard the Magnet
TL;DR: A revised implantation protocol is recommended in which audible confirmation of sensing for 30 to 60 seconds by means of a sterile magnet is performed twice (with a pacemaker, if present in DOO or VOO mode): at the time of system test before induction of arrhythmia with testing cables connected to permit recording of rate, morphology, and ECG interpretation channel signals.
2
Lithotripsy in a patient with an automatic implantable cardioverter defibrillator.
TL;DR: The preparation and management of a patient with an AICD for ESWL of a right renal calculus and a possibility of shock wave damage to the A ICD generator are reported.
2
Transvenous versus transthoracic cardioverter-defibrillator implantation. A comparative analysis of morbidity, mortality, and survival.
David M. Shahian,Warren A. Williamson,Lars G. Svensson,Richard S. D’Agostino,David Martin,Jonathan R. Ellis,Ferdinand J. Venditti +6 more
TL;DR: Transvenous implantation of a cardioverter-defibrillator is associated with a lower incidence of postoperative respiratory complications and atrial fibrillation and total cardiac mortality and freedom from sudden cardiac death in the transvenous and transthoracic groups were comparable at 2 years.
2